http://www.evrs.eu/medias/2010/congress/Proliferative-Diabetic-Retinopathy.flv Mario R. Romano, C. Costagliola, P. Vinciguerra (Milan, Italy) Advantages: Intravitreal Bevacizumab is efficacious as pre-operative adjuvant treatment rather than intra-operative, for the management of recurrent postoperative hemorrhages in patients with advanced proliferative diabetic retinopathy (PDR). Methods: The patients were divided in two groups: Group A...

Read More